Sep. 18
2018
Sept 18, 2018 - PMD-026, the first RSK inhibitor to demonstrate potential disease-modifying properties in TNBC, is now fully funded through IND
Read the full story on PR Newswire here
Sept 18, 2018 - PMD-026, the first RSK inhibitor to demonstrate potential disease-modifying properties in TNBC, is now fully funded through IND
Read the full story on PR Newswire here